Lonza is at long last shedding its capsules and health ingredients (CHI) business in a private equity sale that could see proceeds of 3 billion Swiss francs ($4 billion) or more. | Under the deal ...
Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - Swiss pharmaceutical manufacturer Lonza Group AG (LONN.S) is in advanced talks to acquire Capsugel, a U.S. maker of ...
Morristown, N.J. – April 28, 2014 – Capsugel today announced an agreement with Chiasma, Inc., wherein Capsugel's Dosage Form Solutions (DFS) business unit is scaling up manufacturing for the only ...
Capsugel’s intrinsically enteric capsule technology provides enteric protection and delayed release without a functional coating. Merck’s Parteck SRP 80 sustained-release excipient is well suited for ...
Pfizer, which recently told Wall Street it planned to slim down its business, said it would sell off capsule-maker Capsugel to the private equity group KKR for nearly $2.38 billion. Capsugel makes a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results